NCT04904575 Erector Spinae Plane Block in Lumbar Spinal Fusion
| NCT ID | NCT04904575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinique Saint Jean, France |
| Condition | Lumbar Spinal Fusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2022-01-03 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2022-01-03 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to observe or not a reduction in the consumption of morphine within 72 hours of the realization of an erector spinae plane block when preparing for a lumbar spinal fusion.
Eligibility Criteria
Inclusion Criteria: * Patient with medical insurance. * Patient who received information about study and signes a consent to participate in the study. * Major patient requiring a lumbar spinal fusion surgery. * Patient with an ASA score of 1, 2 or 3. Exclusion Criteria: * Minor patient. * Patient with morphine intolerance * Patient with allergy to local anesthetics. * Patient consuming morphine for more than 3 months. * Pregnant or breastfeeding patient. * Patient scheduled for cancer surgery or trauma surgery. * Patient participating in another interventional study. * Patient with history of lumbar spinal fusion. * Patient requiring lumbar surgery without arthrodesis. * Patient requiring lumbar surgery with inter-lamar or inter-epineal stabilization. * Patient refusing to sign the consent form. * Patient for whom it is impossible to give informed information. * Patient under the protection of justice, under curatorship or under tutorship.
Contact & Investigator
Guillaume LONJON, MD
PRINCIPAL INVESTIGATOR
Clinique Saint Jean, Saint Jean de Védas
Frequently Asked Questions
Who can join the NCT04904575 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lumbar Spinal Fusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04904575 currently recruiting?
Yes, NCT04904575 is actively recruiting participants. Contact the research team at julie.soulier@capsante.fr for enrollment information.
Where is the NCT04904575 trial being conducted?
This trial is being conducted at Saint-Jean-de-Védas, France.
Who is sponsoring the NCT04904575 clinical trial?
NCT04904575 is sponsored by Clinique Saint Jean, France. The principal investigator is Guillaume LONJON, MD at Clinique Saint Jean, Saint Jean de Védas. The trial plans to enroll 130 participants.